Abdulazeez Salawu, MBBS, MSc, PhD - The Case for Biomarker-Guided Management of mCRC: Steps to Refine Care Along the Patient’s Journey PeerVoice Oncology & Haematology Video

Visit https://www.peervoice.com/WVT860 to view the entire programme with slides. After completing “Abdulazeez Salawu, MBBS, MSc, PhD - The Case for Biomarker-Guided Management of mCRC: Steps to Refine Care Along the Patient’s Journey”, participants will be able to: Outline the importance of biomarker testing in metastatic colorectal cancer (mCRC); Illustrate how tumour-sidedness and biomarkers may inform treatment decisions in patients with mCRC; and Discuss the latest evidence with targeted therapies for mCRC.